TY  - GEN
AU  - Carmona Martinez,Alfonso
AU  - Prymula,Roman
AU  - Miranda Valdivieso,Mariano
AU  - Otero Reigada,Maria Del Carmen
AU  - Merino Arribas,Jose Manuel
AU  - Brzostek,Jerzy
AU  - Szenborn,Leszek
AU  - Ruzkova,Renata
AU  - Horn,Michael R
AU  - Jackowska,Teresa
AU  - Centeno-Malfaz,Fernando
AU  - Traskine,Magali
AU  - Dobbelaere,Kurt
AU  - Borys,Dorota
TI  - Immunogenicity and safety of 11- and 12-valent pneumococcal non-typeable Haemophilus influenzae protein D-conjugate vaccines (11vPHiD-CV, 12vPHiD-CV) in infants: Results from a phase II, randomised, multicentre study
SN  - 1873-2518
PY  - 2019///0606
KW  - Antibodies, Bacterial
KW  - blood
KW  - Bacterial Proteins
KW  - genetics
KW  - Carrier Proteins
KW  - Diphtheria-Tetanus-Pertussis Vaccine
KW  - administration & dosage
KW  - Female
KW  - Haemophilus influenzae
KW  - Hepatitis B Vaccines
KW  - Humans
KW  - Immunization, Secondary
KW  - Immunogenicity, Vaccine
KW  - Immunoglobulin D
KW  - Infant
KW  - Lipoproteins
KW  - Male
KW  - Pneumococcal Infections
KW  - immunology
KW  - Pneumococcal Vaccines
KW  - adverse effects
KW  - Poliovirus Vaccine, Inactivated
KW  - Serogroup
KW  - Streptococcus pneumoniae
KW  - Vaccines, Combined
KW  - Vaccines, Conjugate
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/j.vaccine.2018.07.023
ER  -